Two grams of scopolamine can kill a human being, but dogs and cats can stand a hundred times higher dosage. A single Amoenita phalloides mushroom can wipe out a whole human family, but is health food for the rabbit, one of the favorite laboratory animals. A porcupine can eat in one lump without discomfort as much opium as a human addict smokes in two weeks, and wash it down with enough prussic acid to poison a regiment of soldiers. The sheep can swallow enormous quantities of arsenic, once the murderer's favorite poison. Morphine, which calms and anaesthetizes man, causes maniacal excitement in cats and mice. On the other hand our sweet almond can kill foxes, our common parsley is poisonous to parrots, and our revered penicillin strikes another favorite laboratory animal - the guinea-pig - dead. MAN AND ANIMALS
This list can be lengthened at will, but these few instances should suffice to show that there couldn't be a more unreliable test for new drugs (that aren't needed in the first place) than animal experimentation.
The so-called health authorities and researchers are fully aware of this fact, but they continue serving the same warmed-over dish to the media and the public:
Do you want us to test new drugs on your children?In fact, all synthetic products are harmful, and all new drugs are being tested on you and your children, all the time, because the animal tests, which, it bears repeating, have just an alibi function, could give no answer; or, worse, have given misleading answers as to their effect on human beings. This rule knows no exception.In fact, the therapeutic disasters, steadily on the increase today, did not exist before the imposition of the safety-tests done on animals. They are a direct result of the widespread animal experimentation.
Without a large number of always new synthetic medicines with mysterious or magic sounding names to fall back on, most of today's physicians wouldn't know how to ply their trade. And yet at medical school they only get limited instruction in pharmacology, because the teachers themselves can't keep up with the steady flow of new products that invade the market to replace those that must be withdrawn when it is no longer possible to conceal their uselessness or harmfulness. THE POISON PUSHERS
The young doctors start learning their profession only when they leave medical school, and direct contact with patients starts. At the same time begins their real pharmacological education, which will accompany them through their career. This education is conducted by the flood of brochures from the drug manufacturers, and their travelling salesmen, who pay them personal calls at regular intervals, bearing gifts like gold fountain pens or invitations to duck-shoots - besides satchels full of samples of "new" drugs which they advise to try out on the patients and then to report (against remuneration) their finding. This shows clearly that the laboratory experiments have taught them nothing.
In other words, the budding doctor does not receive his medical education from his teachers at medical school, whose knowledge has gotten stuck several years earlier, but by high-pressure salesmen of industrial complexes, whose purpose is not the people's health (a healthy population means a dead pharmaceutical industry) but ever growing profits.
Any doctor who reads the descriptive leaflets accompanying the drugs assumes that they are compiled by someone who is expert in human disease. Very few realize that they are written by people who have never spent five minutes at a patient's bedside, and have only zoological experience. But whether aware of this or not, most doctors seem happy to have always new drugs to fall back on.
In an almost embarrassing example of candor in this respect, Dr. Carl E. Pochedly, identified by Science Digest in its January 1980 issue as an oncologist (cancer expert) specializing in infantile cancer, made the following confession:
"The large number of chemotherapeutic drugs now available increase the oncologist's ability to cope with the child with cancer whose disease is becoming refractory to therapy. Always having a new drug to try increases the physician's composure in this situation. Having a large repertoire of drugs means fewer situations in which the frustration of nothing one can do predominates."Note the distinction "to cope with the child with cancer", when one can't cope with the cancer itself, which the doctor quite honestly describes as "refractory to therapy" - meaning incurable. But thanks to the steady stream of new drugs that have not yet proven their uselessness or their danger, as have the ones they are replacing, the physician can give the child and the parents the impression that "something new is being done."Some doctors need the jolt of a malpractice suit to be awakened to the realization that they have been degraded to the status of mere agents of a huge, profit-oriented industry, which systematically mis-leads them and the public. It's already some years ago that Time (June 9, 1975) reported that patients' malpractice suits, once rare, had become so common that the average annual premiums for high-risk specialists in California, for example, had soared one year from $ 5,377 to $ 22,704.
This jump, reflecting similar jumps elsewhere, is fully justified when we consider the rapidly growing damages caused by the administration of drugs, all found safe on animals before being prescibed for humans. The examples that follow are far from exhaustive. They represent but a tiny fraction of a huge and constantly growing list.
CONSEQUENCES Due to a "safe" painkiller, Paracetamol, 1,500 people had to be hospitalized in Great Britain in 1971; as usual, a good number of them were further damaged by the therapy imposed upon them while in hospital.At about the same time, in the United States Orabilex caused kidney damages with fatal outcome, MEL/29 caused cataracts, and Methaqualone caused severe psychic disturbances leading to at least 366 deaths, mainly through murder or suicide.
Germany's Thalidomide, which caused at least 10,000 malformed children, was merely the first of a quickly growing list of teratogenic (malformation-causing) drugs, that have dramatically increased the number of birth defects ever since the compulsory animal tests as an alleged safeguard against that kind of mishap have been imposed.
In 1972 the aerosol spray, Isoproterenol, packaged in Great Britain, was found by Dr. Paul D. Stolley of Johns Hopkins Hospital as being responsible for the mysterious epidemic that had killed world-wide as many as 3,500 asthma sufferers in the Sixties.
Stilboestrol caused cancer in young women. In the fall of 1975, Italy's health authorities seized the anti-allergic Trilergan, which had caused the very viral hepatitis that the researchers had been promising to eliminate once and for all many years ago but which has been spreading steadily since then.
In early 1976 the Salvoxyl-Wander laboratories of Switzerland's Sandoz complex withdrew their Flamanil, advertised to fight rheumatism, but which had turned out to cause loss of consciousness.
A few months later, Great Britain's gigantic ICI (Imperial Chemical Industries) announced that it had started paying compensations to the victims (or their survivors) of its cardiotonic Eraldin, and resorted to the usual alibi that the drug had been introduced on the market only after 7 years of "very intensive laboratory tests" - meaning on animals - which had given the poisonous medication a clean bill of health. By then, countless consumers had suffered severe damages to the eyes and digestive tract, and many had died.
In the summer of 1977, the Swiss multinational Ciba-Geigy had to withdraw from the American market its Phenformin, which had been palmed off on diabetics for 18 years: it was no longer possible to conceal that its collateral effects had caused about 1,000 deaths annually. Nevertheless, after this had been announced in the press, the Health authorities in the German Federal Republic gave its own drug manufacturers a helping hand and a whole year's time - until July 1st, 1978 - to sell off their stocks of lethal anti-diabetic drugs, including Dipar, Silubin-Retard and Sindatil. Clearly, what mattered was not the public's health but the Syndicate's profits.
The International Herald Tribune of Dec. 23/24, 1978 reported under the heading "Germany Bans Drug Against Cholesterol":
A cholesterol-lowering drug taken mostly by middle-aged men in hopes of preventing heart attacks will be banned by West Germany on the basis of a study of serious and sometimes fatal side effects. American physicians prescribe the drug, clofibrate, for an estimated 450,000 men and 290,000 women. The trade name used in the United States is Atromid S.On September 11, 1979, a panel of doctors and former Valium addicts told a U.S. Senate Subcommittee on Health that Valium, a tranquilizer taken routinely by more than 15 percent of the adult population. was potentially addictive even in moderate doses. The former users said they experienced agonizing withdrawal symptoms when zbev tried to drop the drug, and they complained that their doctors never informed them of the drug's potential addictive qualities when first prescribing it.The West German ban takes effect Jan.15 and applies to 24 companies that sell drugs containing clofibrate. Imperial Chemical Industries of Britain says it will protest the ban as medically unjustified and is considering legal action against the West German government. One major finding of the study leading to the ban was that long-term clofibrate users did not have fewer fatal heart attacks than comparable non-users. However, clofibrate users in the study had a sharply higher rate of deaths from cancer and other diseases - principally of the liver, gall bladder and intestines... (Emphasis supplied.)
Meanwhile: THE LEGALIZED MASSACRE (CONTINUED)
Preludin and Maxiton, "pep pills" also used to reduce appetite, are withdrawn from the market after causing serious damages to the heart and the nervous system.
Barbiturates (Nembutal etc.), prescribed against insomnia, turn out in the long run to increase insomnia instead of curing it.
Pronap and Plaxin, two tranquilizers, have killed many babies in South Africa and were withdrawn in 1970.
Phenacetin, only recently taken off the market in the United States, is a painkiller sold in various compositions under 200 different brand lables. It can block the kidney functions, destroy the kidneys, cause kidney tumors and destroy the red blood corpuscles.
Amydopyrine, another pain-killer, has caused lethal damage to the blood, including agranulocytosis, and has been withdrawn in many countries, but not in all. It occurs in Salgydal, in association with Phenacetin, in Optalidon and in over 160 other products.
Marzine, used against nausea and travel sickness, has been withdrawn in 1971 in many countries (for example in Switzerland and Italy) because of the grave damage it inflicts, especially on children.
Reserpine, prescribed to reduce blood pressure, has been shown to increase threefold the risk of breast cancer in women. It is also considered to increase the risk of cancer of the brain, the pancreas, the uterus, the ovaries and the skin. It is furthermore famous for causing nightmares and depression.
Methotrexate, used against leukemia and psoriasis, has caused ulceration of the mouth cavity, hemorrhages of the alimentary tract with intestinal perforation, severe anemia, and has triggered or intensified cancerous tumors.
Urethane, used in the past to cure leukemia (considered a cancer of the blood), has meanwhile turned out to be capable of causing cancer of the liver, lungs and bone marrow.
Another drug administered to cure leukemia, Mitotane, causes necrosis (death) of the renal glands.
Cyclophosphamide, another drug advertised to fight cancer, provokes widespread necroses which start in the liver and the lungs and usually kill the patient much sooner than the cancer would, as do most drugs employed to "check" cancer by chemotherapy.
The antibiotics Isoniazid, used against TB, cause liver necrosis.
Kanamycin, an antibiotic also used against TB, affects the auditory nerves and causes kidney insufficiency.
Chloramphenicol (Chloromycetin), an antibiotic employed against tyhoid fever, may cause the destruction of bone marrow, severe anemia, and cardiovascular collapse leading to death.
Bismuth, prescribed against diarrhea as well as against constipation (!), causes severe trouble: in France, a thousand cases of intoxication since 1974, with at least 28 deaths and uncounted cerebral troubles.
Phenolphthalein, used in many laxatives, has caused vomiting, albumin in the urine (indicating damage to the kidneys), delirium and death.
"A 'Miracle Drug' That Backfired" was the title of an International Herald Tribune article on January 14, 1981. It began by recalling that American physicians had started prescribing Clofibrate massively 13 years before. because:
The drug seemed to offer modern man the luxury of having his cake and eating it too - that is, of continuing to devour steak and butter without fear of heart attack just by taking a little capsule four times a day... Far from saving lives, it now appears Clofibrate actually increa-ses the death rate among its users. A decade long study run by the World Health Organization (WHO) recently reported that men regularly taking the drug were 25 percent more likely to die of a broad range of disorders, including cancer, stroke, respiratory disease and, ironically, heart attack, than those who got a placebo capsule.But don't get depressed, folks. Thousands of other confused or just grant-hungry scientists are currently busy using up millions of fresh animals trying to find new products capable of neutralizing the disastrous side-effects of Clofibrate and other miracle drugs.
The systematic fraud perpetrated by the all-powerful Chemical Syndicate in collusion with the various Health Institutes to the detriment of the world population's health is growing day by day. And yet proof comes to light day after day that the "new drugs" (in actual fact they are mostly the same old drugs - identical ingredients sold in varying combinations and under different labels) are not only incapable of curing diseases that nature couldn't cure by herself if given half a chance, but are constantly producing brand new diseases, unknown a few years ago. The Oxychinol Case
In August 1978 came the news from Japan that a Tokyo court had found three drug manufacturers and the Japanese government guilty of selling drugs containing Oxychinol (also called Clioquinol), responsible for a new, severe disease of the nervous system - subacute myelo-optic neuropathy, or SMON for short. The manufacturers - Takeda, Ciba-Geigy Japan and Tanabe Seijaku - were sentenced along with the Japanese Health authorities to pay indemnities of 3.25 billion Yen (appr. $17 million or £5 million) to 133 plaintiffs. This was the conclusion of but the first of over 20 court cases currently (1982) under way.
The plaintiffs had demonstrated that SMON was caused by drugs that had been sold under the pretext that they would miraculously cure what the manufacturers had defined as "summer diarrhea", a highly unscientific definition for a mild intestinal disorder that affects a great number of travelers in tropical lands; Americans variously call it "the "GI's" or "Montezuma's revenge", and the British "Spanish tummy", and it usually clears up without treatment within 48 hours.
That is, unless one takes the "miracle" drug Oxychinol that Ciba-Geigy had developed several years earlier, and marketed world-wide under different labels (Mexaform, Entero-Vioform, Intestopan, Sterosan, etc.), recommending them to travelers at the first sign of indigestion, and even prophylactically; i.e. before developing any intestinal troubles (which this drug causes!).
At least a thousand deaths had to be counted in Japan and 30,000 cases of blindness and/or paralysis of the lower limbs before it was realized that heretofore unexplained similar cases of death, blindness and paralysis in Holland, Denmark, Germany, France, Great Britain, Belgium, Italy, Sweden, etc. had also been caused by Oxychinol-containing drugs.
These finding exploded Ciba-Geigy's lame alibi that only Japanese had been adversely affected by this drug and that therefore the Japanese were themselves to blame for their national catastrophe, having fallen for the manufacturers' claims with exaggerated confidence!
In 1979 a Swedish medical doctor, Olle Hansson, Professor of pediatric neurology at Göteborg University, published in a book the findings of the Tokyo court, which had summoned him to testify at the first Oxychinol trial. * In this book he leaves no doubts about the fact that some big drug manufacturers do not hesitate to walk over corpses - human corpses - for the sake of profits, and resort to any and every kind of lie to conceal the fact that pecuniary gain is their ruling motivation.
In Japan alone, Oxychinol was sold under 168 different brand names.
The many shocking findings of Dr. Olle Hansson's study include the disclosure of Ciba-Geigy's own research protocols, dated as far back as June 19, 1939, showing that the Swiss researchers managed to poison a goodly number of animals, who were seized by violent convulsions and respiratory difficulties as soon as they were made to swallow Oxychinol, and most of them finally met painful a death.
In spite of these results, which were kept secret, Ciba-Geigy proceeded to market its dangerous drug world-wide, limiting itself to publishing a warning in its accompanying leaflets to the effect that the drug should not be administered to house pets.
What does this prove? Clearly, that the researchers themselves do not believe in the validity of animal tests in respect to human beings.
On April 28, 1980, at the Hotel Penta in Geneva, a press conference on SMON was held for 37 international reporters, organized by a Japanese committee. Participants included lawyers and medical authorities from Japan, Malaysia, Australia, the Netherlands, United-Kingdom, Switzerland, Sri Lanka, USA, France, Sweden, Norway, Italy.
It emerged from that conference that Ciba-Geigy had disregarded the ill-effects of its Clioquinol in animals, obviously knowing full well that animal tests are valueless, and proceeded to market these drugs worldwide for human consumption anyhow.
The Proceedings of that conference were then published in Japan. Excerpts from the Preface by Hiroshi Izumi, Attorney-at-Law from Tokyo:
It has been nine years since SMON victims first undertook legal action in court against the State, Ciba-Geigy (Japan) Limited, Takeda Chemical Industries Ltd., and Tanabe Seiyaku Co., Ltd. The number of plaintiffs since that lawsuit on May 28, 1971 has now reached 5,500.The Tokyo District Court ruled on the SMON case on August 3, 1978. At that time, the Court noted:
"The Ciba-Geigy head office in Basel investigated reports that dogs given Entero-Vioform or Mexaform often developed epileptiform seizures and died, and the company circulated a warning among veterinarians not to use these drugs in veterinary treatment. However, although these drugs were produced for human use, they not only did not take any measures to warn about the dangers of use by humans, but also, as previously mentioned, they continued to stress thereafter the safety of Entero-Vioform and Mexaform in Japan.
They still continue selling Clioquinol in many countries without adequate warning...
Mrs. Heidi Anderson, a Swedish woman who participated in this press conference, had been diagnosed as having multiple sclerosis, but today it is clear that she is a victim of Clioquinol-induced SMON. So we presume that there are still many other SMON victims in Europe.
It is a criminal act that Ciba-Geigy and other multi-national pharmaceutical companies continue to sell drugs in the Third World which are prohibited in the developed countries."
(Geneva Press Conference on SMON, Proceedings, Copyright 1980 by the Organizing Committee of Geneva Press Conference on SMON, 5th Fl., Yamaichi Bldg., Tokyo 160)
- from NAKED EMPRESS or the Great Medical Fraud , CIVIS, pp. 13- 21